[PDF] Top 20 C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis

... Our analysis indicated different cut-off points among each study, ranging from 3 to 50 mg·L −1 and from 3 to 500 mg·L −1 in those focusing on late and early mortality, ...late mortality, we performed ... See full document

... a systematic review and meta-analysis to compare the efficacy and safety of tiotropium and salmeterol in patients with ...on COPD were ...disease. Meta-analysis was ... See full document

... impedance analysis devices to measure lean ...impedance analysis, an inexpensive alternative to dual-energy X-ray absorptiometry, is dependent on the formula used [70], which differed among these ...this ... See full document

... sensitivity analysis, meta-regression analysis, and subgroup analysis, to investigate the possible sources of heterogeneity, and as far as possible, to reduce the occurrence of type I error in ... See full document

... of COPD, especially patient in stability, are often based on invigorating spleen for benefiting ...this systematic review indicate that the use of SLBZS plus conventional therapy could significantly ... See full document

... moderate COPD compared with 34% in the general ...to COPD that may contribute to a higher pain prevalence in patients with ...with COPD and inactivity may aggravate common age-related comorbidities ... See full document

... lower mortality in patients with CHF. Thus, carvediolol’s mortality reduction in COPD patients may be more profound than that of beta-selective ...six COPD patients with no previous history of ... See full document

... investigators will independently screen, select studies, and extract data, with discrepancies resolved by consensus or arbitrarily by a third investigator. Risk of bias and methodological quality of the included studies ... See full document

... In the study by Forman et al.(2008) in a 1484 young women (aged 32 to 52 years)found that although vitamin D supplementation did not lower CRP specifically, it did lead to improvements in other inflammatory markers, for ... See full document

... and mortality [1, 2, ...treatment. C-reactive protein (CRP) is produced by the liver in response to inflammation and/or infectious stimuli, and thus it is considered to be an acute-phase ... See full document

... the meta-analysis and were eligible for ...present meta-analysis provide evidence that a healthy/prudent pattern decreases CRP level, while adherence to unhealthy/Western pattern leads ... See full document

... patient level), age group (children vs adults) and whether or not CRP cut-off guidance was ...performed meta-regression using the metareg function (meta package in R) to assess whether heterogeneity ... See full document

... Three authors (Huang, Feng, and Liu) reviewed the included studies and extracted the data independently. If the results reported overlapped, only the most recent or the most com- plete study was used in the ... See full document

... Increased concentration of CRP is associated with increased risk of cardiovascular diseases and mortality (11), colorectal cancer (12) and lung cancer (13). Poorer prognosis in cancer patients, including those of ... See full document

... between C-reactive protein (CRP) lev- els and all-cause mortality and cardiovascular disease mortality in patients undergoing peritoneal dialysis ...A systematic literature ... See full document

... (PCT), C-reactive protein (CRP), lipopolysaccharide-binding protein (LBP), interleukins, provasopressin, and myeloid cells expressing triggering receptor-1 (TREM-1) ...previous review ... See full document

... RBC transfusion is current standard practice for correct- ing anemia in critically ill patients, and it would be lo- gical to continue this in a future trial. Iron therapy plus or minus erythropoietin would be another ... See full document

... as mortality rates of participants during follow-up, number and type of complications as- sociated with liver cirrhosis and if possible person-time data, incidence rates and hazard ... See full document

... in COPD patients is CRP (4). This factor is increased in COPD patients and relates to the pulmonary ...of mortality in mild and moderate forms of COPD is cardiovascular disease ... See full document

... DPP-4i improve glycemic control via preventing the inactivation of incretins, such as glucagon-like peptide-1 and glucose dependent insulinotropic peptide [14, 15]. DPP-4i improve pancreatic β-cell function in both fast- ... See full document